AK-Con (Preferred Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the AK-Con drug offered from Preferred Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Preferred Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Naphazoline Hydrochloride
SUBSTANCE NAME: NAPHAZOLINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-03-24
END MARKETING DATE: 0000-00-00


AK-Con HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAK-Con from Preferred Pharmaceuticals, Inc.
LABELER NAME: Preferred Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2005-03-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68788-0446_a27604ba-036c-4840-aac8-55dcaa402144
PRODUCT NDC: 68788-0446
APPLICATION NUMBER: ANDA083590

Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Naphazoline
Insight PharmaceuticalsPrivine
Insight Pharmaceuticals LLCPrivine
International Nature NutraceuticalsPi Yen Chin
Preferred Pharmaceuticals, Inc.AK-Con
Proficient Rx LPNaphazoline
Rebel Distributors Corp.AK-Con
Sato Pharmaceutical Co., Ltd.Sato Clear